| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |